Most Popular in Regulatory
- 1Could the FDA Sunscreen Monograph See a New Addition?
- 2EPA Eyes 20 Chemicals for High Priority Risk Evaluation, ACC Responds
- 3DSM Seeks FDA Sunscreen Monograph Approval of Bemotrizinol
- 4Into the Weeds: Walking the Regulatory Line of CBD in Cosmetics
- 5FDA Issues Warning Letter for Eyebrow/Eyelash Growth Product Claims
- 6[podcast] Why the FDA Disallows Europe’s Sunscreens
- 7EU Effectively Bans D4 and D5 in Wash-off Products
- 8The INCI Name Game: A Commentary
- 9Korean Cosmetic Regulations
- 10Dubai Cracks Down on Banned Substances in Cosmetics
Recent in Regulatory (page 1 of 38)
Aug 29, 2019
DSM believes it is important for consumers in the USA to benefit from the efficacy and aesthetics that modern filters such as BEMT can provide. As such, the company is pushing for Monograph status.
Aug 28, 2019
It's been decades since the FDA's OTC Sunscreen Monograph welcomed a new addition; back then, it was avobenzone. Now, another could be joining the ranks.
Aug 23, 2019
"EPA is providing a 90-day comment period during which interested persons may provide comments on the proposed designations of High-Priority Substances for risk evaluation." Read on to learn more.
Aug 20, 2019 | Tony O'Lenick, IFSCC and Siltech LLC; and the late Johann W. Wiechers, Ph.D., Formulating for Efficacy Software
As we use terms that have scientific meaning, marketing meaning and common meaning, we will always be confused as to which meaning is in use. Read on to see what O'Lenick and Wiechers have to say about this.
Aug 12, 2019
Illinois has become the third state in the U.S. to prohibit the sale of cosmetics that have been tested on animals. Read on for details and exceptions.
Aug 2, 2019
CVS store-brand sunscreen products will no longer contain certain sunscreen ingredients thought to damage marine ecosystems.
Jul 31, 2019
Industry organizations worry that consumers may be deterred from using sunscreens—causing unintended negative health effects—due to the U.S. Food and Drug Administration's recent sunscreen proposals.
Jul 25, 2019
The agency has issued a warning letter to Curaleaf Inc., for illegally selling unapproved products containing cannabidiol (CBD) online. The company is accused of making unsubstantiated claims that the products treat cancer, Alzheimer’s disease and opioid withdrawal, among other conditions or diseases.
Jul 18, 2019
Having already made the REACh list of chemicals requiring authorization, four phthalates are now recommended by European legislators to be flagged as endocrine disruptors.
Jul 12, 2019 | Rachel Grabenhofer
When misinformed groups play in a technical space, nontechnically trained regulators make irrelevant rules, and INCI names are generalized and misused, you have the perfect storm for consumer confusion.
Jul 9, 2019
A U.S. Congressman has requested data from the U.S. Food and Drug Administration on its policies on cosmetic imports.
Jul 3, 2019
Per an EU statement the deal will remove the majority of tariffs on EU exports to Mercosur, which is comprised of Argentina, Brazil, Paraguay and Uruguay, as well as several associate members.